p. 13337 - 13347
(2021/11/20)p. 12120 - 12128
(2021/07/19)p. 4057 - 4061
(2021/05/26)p. 3008 - 3014
(2021/01/18)p. 9938 - 9943
(2020/06/27)p. 16903 - 16915
(2020/12/18)p. 14500 - 14509
(2020/04/27)p. 6210 - 6214
(2019/06/27)p. 7582 - 7588
(2019/05/16)p. 6755 - 6764
(2019/05/06)p. 4430 - 4435
(2019/04/29)p. 4131 - 4139
(2018/04/14)p. 196 - 206
(2017/08/10)p. 1786 - 1789
(2017/02/15)p. 65 - 69
(2017/01/09)p. 3422 - 3434
(2016/11/13)p. 117 - 124
(2016/01/26)p. 3124 - 3128
(2016/03/12)p. 1733 - 1740
(2015/06/16)p. 6016 - 6024
(2013/07/26)p. 1410 - 1413
(2013/05/09)p. 195 - 203
(2013/04/10)p. 96 - 99
(2013/03/28)p. 23 - 30
(2013/02/23)p. 754 - 763
(2012/03/12)p. 1283 - 1290
(2012/01/31)p. 1 - 8
(2011/12/14)p. 6052 - 6055
(2011/06/25)p. 149 - 153
(2011/08/05)p. 2995 - 2997
(2010/08/05)p. 16737 - 16740
(2011/02/17)p. 2004 - 2008
(2010/06/20)p. 5930 - 5932
(2010/01/18)p. 10201 - 10210
(2009/12/08)p. 15606 - 15607
(2010/01/30)p. 7532 - 7533
(2009/10/16)(2008/06/13)
p. 477 - 481
(2007/10/03)p. 4656 - 4661
(2007/10/02)p. 8388 - 8398
(2007/10/02)p. 2739 - 2742
(2007/10/02)p. 1042 - 1049
(2007/10/02)p. 299 - 306
(2007/10/02)Isopropylbenzene
phenyl radical
2-biphenyl-4-yl-propan-2-ol
N-α-Bpocglycine
biphenyl-4-acetaldehyde